The current proposal represents our continued studies of the histogenesis and differentiation lineages underlying the formation of the major forms of human lung cancer. We will focus upon initial findings that the 5' region of the calcitonin gene has a unique hypermethylation pattern in DNA extracted from patients with lung cancer and with lymphomas. Among the spectrum of lung cancers, the hypermethylation pattern is most extensive in classic small cell lung cancer (SCLC) and a less extensive, but abnormal pattern, is also found more frequently in so-called """"""""variant"""""""" SCLC cells. Within the spectrum of the major types of human lung cancer, the incidence for the presence of the abnormal methylation pattern parallels that for the distribution of a marker for neuroendocrine differentiation. The present studies are designed to extend our observations regarding the incidence of the abnormal methylation pattern in human cancers, to determine whether the patterns are unique to tumor DNA or might reflect the cell compartments in normally renewing adult tissues from which individual types of lung cancers and/or lymphomas arise, to correlate the degree of hypermethylation with patterns of expression for the CT gene, and to ascertain whether the methylation patterns might serve as markers for refining the diagnostic categories of lung cancer in a clinically significant manner. Techniques to be used in these studies include cell culture, DNA-DNA hybridization, DNA-RNA hybridization, Southern and Northern blotting techniques.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043318-02
Application #
3185506
Study Section
Biochemistry Study Section (BIO)
Project Start
1986-09-30
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Vaz, Michelle; Hwang, Stephen Y; Kagiampakis, Ioannis et al. (2017) Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations. Cancer Cell 32:360-376.e6
Zhang, Yang W; Wang, Zhihong; Xie, Wenbing et al. (2017) Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress. Mol Cell 65:323-335
Chiappinelli, Katherine B; Zahnow, Cynthia A; Ahuja, Nita et al. (2016) Combining Epigenetic and Immunotherapy to Combat Cancer. Cancer Res 76:1683-9
Sen, Subhojit; Block, Kirsten F; Pasini, Alice et al. (2016) Genome-wide positioning of bivalent mononucleosomes. BMC Med Genomics 9:60
Easwaran, Hariharan; Tsai, Hsing-Chen; Baylin, Stephen B (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54:716-27
Ahuja, Nita; Easwaran, Hariharan; Baylin, Stephen B (2014) Harnessing the potential of epigenetic therapy to target solid tumors. J Clin Invest 124:56-63
Cai, Y; Geutjes, E-J; de Lint, K et al. (2014) The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes. Oncogene 33:2157-68
Cui, Ying; Hausheer, Frederick; Beaty, Robert et al. (2014) A recombinant reporter system for monitoring reactivation of an endogenously DNA hypermethylated gene. Cancer Res 74:3834-43
Park, Tea Soon; Bhutto, Imran; Zimmerlin, Ludovic et al. (2014) Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature. Circulation 129:359-72
Azad, Nilofer; Zahnow, Cynthia A; Rudin, Charles M et al. (2013) The future of epigenetic therapy in solid tumours--lessons from the past. Nat Rev Clin Oncol 10:256-66

Showing the most recent 10 out of 108 publications